Results 121 to 130 of about 3,610 (188)

Editorial: Women in CNS drug delivery: 2022-2024. [PDF]

Front Drug Deliv
Veszelka S, Burek M, Thomas SA.
europepmc   +1 more source

Advancing neuroblastoma care: future horizons after approval of eflornithine by FDA. [PDF]

Int J Surg
Nazir A, Nazir A, Kandel K.
europepmc   +1 more source

Scientific and regulatory progress in advancing paediatric oncology drug development in the EU and in the US. [PDF]

Front Med (Lausanne)
Reggiardo G, Natale A, Santoro N, Giannuzzi V, Pansieri C, Felisi M, Bonifazi D, Ceci A.   +7 more
europepmc   +1 more source

Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review. [PDF]

Medicine (Baltimore)
Shakeel A, Baloch A, Kumari V, Kazmi SKZ, Aftab K, Abid S, Syed A, Syed A, Yousuf J, Hasanain M, Anjum MU, Anjum MU, Mahmmoud Fadelallah Eljack M.   +12 more
europepmc   +1 more source

How Antiparasitic Drugs Work-And Sometimes Stop Working! [PDF]

, 2016
David Horn, Kasturi Haldar
core   +3 more sources

Advanced Inhibition of Undesired Human Hair Growth by PPARγ Modulation [PDF]

, 2020
Bíró, Tamás, Kloepper, Jennifer E., Lisztes, Erika, Mastrofrancesco, Arianna, Paus, Ralf, Picardo, Mauro, Ramot, Yuval   +6 more
core   +1 more source

<i>N</i>-Myristoyltransferase Inhibition in Parasitic Pathogens: Insights from Computer-Aided Drug Design. [PDF]

Molecules
Campos FFGR, Moura WCDS, Romário-Silva D, Araújo RSA, Morais I, Cortes S, Nogueira F, Moura RO, Nascimento IJDS.   +8 more
europepmc   +1 more source

Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l‑Eflornithine

ACS Omega, 2020
Mikael Boberg, Anna C. Jonson, Hanna Leek, Rasmus Jansson-Löfmark, Michael Ashton   +4 more
doaj   +1 more source

Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of <i>Trypanosoma brucei rhodesiense</i>. [PDF]

Pharmaceuticals (Basel)
Di Chio C, Starvaggi J, Previti S, De Luca F, Natale B, Cosconati S, Schirmeister T, Zappalà M, Ettari R.   +8 more
europepmc   +1 more source

Interventions for Neglected Diseases Caused by Kinetoplastid Parasites: A One Health Approach to Drug Discovery, Development, and Deployment. [PDF]

Pharmaceuticals (Basel)
Ebiloma GU, Alhejeli A, de Koning HP.
europepmc   +1 more source